DE3872588T2 - Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen. - Google Patents

Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen.

Info

Publication number
DE3872588T2
DE3872588T2 DE8888106566T DE3872588T DE3872588T2 DE 3872588 T2 DE3872588 T2 DE 3872588T2 DE 8888106566 T DE8888106566 T DE 8888106566T DE 3872588 T DE3872588 T DE 3872588T DE 3872588 T2 DE3872588 T2 DE 3872588T2
Authority
DE
Germany
Prior art keywords
killer cells
lymphokinactivated
producing human
simplified method
centrifugation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888106566T
Other languages
English (en)
Other versions
DE3872588D1 (de
Inventor
Dunn, Jr
Joseph David Irr
Lise Nadine Halpern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Haemonetics Corp
Original Assignee
Terumo Corp
Haemonetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp, Haemonetics Corp filed Critical Terumo Corp
Publication of DE3872588D1 publication Critical patent/DE3872588D1/de
Application granted granted Critical
Publication of DE3872588T2 publication Critical patent/DE3872588T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8888106566T 1987-04-27 1988-04-23 Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen. Expired - Fee Related DE3872588T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/042,998 US4808151A (en) 1987-04-27 1987-04-27 Simplified method for the preparation of human lymphokine activated killer cells

Publications (2)

Publication Number Publication Date
DE3872588D1 DE3872588D1 (de) 1992-08-13
DE3872588T2 true DE3872588T2 (de) 1992-12-03

Family

ID=21924902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888106566T Expired - Fee Related DE3872588T2 (de) 1987-04-27 1988-04-23 Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen.

Country Status (17)

Country Link
US (1) US4808151A (de)
EP (1) EP0289896B1 (de)
JP (1) JPH0657147B2 (de)
KR (1) KR900004422B1 (de)
AT (1) ATE78053T1 (de)
AU (1) AU612086B2 (de)
CA (1) CA1304306C (de)
DE (1) DE3872588T2 (de)
DK (1) DK226288A (de)
ES (1) ES2051790T3 (de)
FI (1) FI881952A (de)
HU (1) HU205380B (de)
IL (1) IL86177A0 (de)
NO (1) NO881819L (de)
NZ (1) NZ224379A (de)
PT (1) PT87335B (de)
ZA (1) ZA882948B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000970A2 (en) * 1986-08-08 1988-02-11 Regents Of The University Of Minnesota Method of culturing leukocytes
AU4485089A (en) * 1988-10-21 1990-05-14 Brigham And Women's Hospital Activation and growth of human tumor-infiltrating lymphocytes using antibodies to cd3 or tcr
JP2955314B2 (ja) * 1988-10-27 1999-10-04 リージェンツ・オブ・ザ・ユニバーシティー・オブ・ミネソタ Ｉｌ―２含有リポソーム免疫アジュバント
US5484396A (en) * 1988-11-17 1996-01-16 Naficy; Sadeque S. Method and device for treatment of HIV infections and AIDS
DE69012105T2 (de) * 1989-02-21 1994-12-22 Terumo Corp Proliferation von cd4-lymfocyten.
US5851828A (en) 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5843728A (en) * 1991-03-07 1998-12-01 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US5912170A (en) * 1991-03-07 1999-06-15 The General Hospital Corporation Redirection of cellular immunity by protein-tyrosine kinase chimeras
US6753162B1 (en) 1991-03-07 2004-06-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US7049136B2 (en) 1991-03-07 2006-05-23 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US6004811A (en) 1991-03-07 1999-12-21 The Massachussetts General Hospital Redirection of cellular immunity by protein tyrosine kinase chimeras
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
CA2116362A1 (en) * 1991-04-05 1992-10-15 Augusto C. Ochoa Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
CA2127107C (en) * 1991-12-31 2007-06-19 Bruce L. A. Carter Methods and compositions for reducing blood loss
US5674173A (en) * 1995-04-18 1997-10-07 Cobe Laboratories, Inc. Apparatus for separating particles
US5951877A (en) * 1995-04-18 1999-09-14 Cobe Laboratories, Inc. Particle filter method
US6053856A (en) * 1995-04-18 2000-04-25 Cobe Laboratories Tubing set apparatus and method for separation of fluid components
DE69637310T2 (de) * 1995-04-18 2008-08-28 Gambro BCT, Inc., Lakewood Vorrichtung und Verfahren zur Teilchentrennung
US6022306A (en) * 1995-04-18 2000-02-08 Cobe Laboratories, Inc. Method and apparatus for collecting hyperconcentrated platelets
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
US6051146A (en) * 1998-01-20 2000-04-18 Cobe Laboratories, Inc. Methods for separation of particles
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US6334842B1 (en) 1999-03-16 2002-01-01 Gambro, Inc. Centrifugal separation apparatus and method for separating fluid components
US6354986B1 (en) 2000-02-16 2002-03-12 Gambro, Inc. Reverse-flow chamber purging during centrifugal separation
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
WO2003050536A2 (en) * 2001-12-05 2003-06-19 Gambro, Inc. Methods and apparatus for separation of blood components
US20030173274A1 (en) * 2002-02-01 2003-09-18 Frank Corbin Blood component separation device, system, and method including filtration
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
DE60322600D1 (de) 2002-04-16 2008-09-11 Gambro Bct Inc System zum Auftrennen von Blutkomponenten, Gerät und Verfahren
CN1291231C (zh) 2003-12-08 2006-12-20 胡军 活化淋巴细胞特异性的检测方法
US20080035585A1 (en) * 2006-08-10 2008-02-14 Gambro Bct, Inc. Method and Apparatus for Recirculating Elutriation Fluids
DE102011106914B4 (de) 2011-07-08 2015-08-27 Zellwerk Gmbh Mäander- Bioreaktor und Verfahren zu dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen
WO2014127122A1 (en) 2013-02-18 2014-08-21 Terumo Bct, Inc. System for blood separation with a separation chamber having an internal gravity valve
WO2017209498A1 (ko) * 2016-06-03 2017-12-07 주식회사 젬백스앤카엘 항암 치료용 사이토카인 유도 살해세포의 생산 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145713A (en) * 1963-09-12 1964-08-25 Protein Foundation Inc Method and apparatus for processing blood
US4197847A (en) * 1977-03-31 1980-04-15 Isaac Djerassi Method and apparatus for collecting transfusable granulocytes
US4185629A (en) * 1977-10-18 1980-01-29 Baxter Travenol Laboratories, Inc. Method and apparatus for processing blood
US4151844A (en) * 1977-11-11 1979-05-01 Baxter Travenol Laboratories, Inc. Method and apparatus for separating whole blood into its components and for automatically collecting one component
US4285464A (en) * 1979-01-22 1981-08-25 Haemonetics Corporation Apparatus for separation of blood into components thereof
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4464167A (en) * 1981-09-03 1984-08-07 Haemonetics Corporation Pheresis apparatus
US4416654A (en) * 1981-09-03 1983-11-22 Haemonetics Corporation Pheresis apparatus
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4675383A (en) * 1983-11-15 1987-06-23 The Salk Institute For Biological Studies Purification of T-cell growth factor
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans

Also Published As

Publication number Publication date
US4808151A (en) 1989-02-28
PT87335B (pt) 1992-08-31
PT87335A (pt) 1988-05-01
FI881952A (fi) 1988-10-28
AU612086B2 (en) 1991-06-27
KR880012751A (ko) 1988-11-29
JPH0657147B2 (ja) 1994-08-03
EP0289896A1 (de) 1988-11-09
FI881952A0 (fi) 1988-04-26
HU205380B (en) 1992-04-28
DK226288A (da) 1988-10-28
ZA882948B (en) 1989-12-27
DE3872588D1 (de) 1992-08-13
DK226288D0 (da) 1988-04-26
NO881819D0 (no) 1988-04-26
AU1520088A (en) 1988-10-27
NZ224379A (en) 1990-12-21
KR900004422B1 (ko) 1990-06-25
ES2051790T3 (es) 1994-07-01
EP0289896B1 (de) 1992-07-08
IL86177A0 (en) 1988-11-15
JPS63295510A (ja) 1988-12-01
NO881819L (no) 1988-10-28
ATE78053T1 (de) 1992-07-15
CA1304306C (en) 1992-06-30

Similar Documents

Publication Publication Date Title
DE3872588D1 (de) Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen.
AU641488B2 (en) Human hematopoietic stem cell
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
AU7262691A (en) Anabolic activity modulator and uses thereof
DE69224124T2 (de) Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid
EP0311283A3 (en) Process for obtaining concentrates having a high alpha-lactalbumin content from whey
DE3684434D1 (de) Verfahren zur herstellung von 2-keto-d-glukarsaeure.
DE3864512D1 (de) Verfahren zur herstellung von kandis mit gepressten gaszellen.
AU1189888A (en) Blood cell separation
ES2052531T3 (es) Metodo para aumentar selectivamente la relacion de los componentes individuales del complejo antibiotico a 40926.
DE3767920D1 (de) Verfahren zur herstellung von alkyloligoglycosiden.
MY103370A (en) A simplified method for the preparation of human lymphokine activated killer cells
DE3770952D1 (de) Verfahren zur herstellung von hydroxylaminen.
ATE95569T1 (de) Verfahren zur herstellung von pregnenooxazolinen.
EP0257962A3 (de) Verfahren zur Behandlung von Umkreisblut für die Verbesserung der lymphokinaktivierten Töterzell-Immuntherapie
DE3681629D1 (de) Cholesterolreiche fraktion, verfahren dafuer und verwendung derselben zur zellkultur.
DE3585646D1 (de) Fermentationsverfahren zur herstellung von karbonsaeurealkylestern.
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
ATE81530T1 (de) Verfahren zur fermentativen herstellung von laminos|uren aus alpha-ketocarbonsaeuren.
DE3785639D1 (de) Verfahren zur herstellung von milchsaeure.
UA6236A1 (uk) Спосіб одержання субстрата для вирощування шампіньйонів
DE59814423D1 (de) Verfahren zur herstellung von humaneigenblutzytokinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee